Active Stocks
Tue Apr 16 2024 15:59:30
  1. Tata Steel share price
  2. 160.05 -0.53%
  1. Infosys share price
  2. 1,414.75 -3.65%
  1. NTPC share price
  2. 359.40 -0.54%
  1. State Bank Of India share price
  2. 751.90 -0.65%
  1. HDFC Bank share price
  2. 1,509.40 0.97%
Business News/ Companies / People/  Paytm’s Vijay Shekhar Sharma youngest Indian billionaire: Forbes
BackBack

Paytm’s Vijay Shekhar Sharma youngest Indian billionaire: Forbes

39-year-old Paytm founder Vijay Shekhar Sharma, with a net worth of $1.7 billion, is ranked 1,394th on Forbes billionaires list

Paytm’s Vijay Shekhar Sharma is one of the only 63 billionaires in the Forbes list who are under the age of 40. Photo: BloombergPremium
Paytm’s Vijay Shekhar Sharma is one of the only 63 billionaires in the Forbes list who are under the age of 40. Photo: Bloomberg

New Delhi: Paytm founder Vijay Shekhar Sharma, 39, is the youngest Indian billionaire, while 92-year-old Samprada Singh, chairman emeritus of Alkem Laboratories Ltd, is the oldest, according to Forbes magazine.

Sharma, ranked 1,394th on the list with a fortune of $1.7 billion, is the only Indian billionaire in the under-40 league. Sharma founded fast-rising mobile wallet Paytm in 2011. He has also created Paytm Mall, an e-commerce business business and Paytm Payments Bank.

“One of the biggest beneficiaries of India’s demonetisation, Paytm has notched up 250 million registered users and 7 million transactions daily. Sharma owns 16% of Paytm, which is now valued at $9.4 billion," Forbes said.

Of the 2,208 billionaires in Forbes’ 2018 list of the world’s richest, just 63 are under the age of 40 and more than half (34) are self-made entrepreneurs. In all, the 63 youngest billionaires in the world are worth a collective $265 billion, up from $208 billion last year.

Meanwhile, 92-year-old Samprada Singh, who is the chairman emeritus of Alkem Laboratories, is the oldest Indian billionaire. He was ranked 1,867th on the list with a net worth of $1.2 billion. Singh founded the pharma firm Alkem Laboratories 45 years ago. Singh worked in a chemist’s store before venturing out on his own distributing pharmaceuticals.

“Shares of the generics maker, known for its antibiotics Clavam and Taxim, have more than doubled since its November 2016 IPO. For the year ended March 2017, Alkem reported a 20% rise in net earnings to $139 million on revenues of $913 million," Forbes said.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 07 Mar 2018, 04:20 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App